Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

AGL vs HUM vs UNH vs CNC vs CVS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
AGL
Agilon Health, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$1.01B
5Y Perf.-92.3%
HUM
Humana Inc.

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$29.67B
5Y Perf.-44.5%
UNH
UnitedHealth Group Incorporated

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$335.60B
5Y Perf.-7.3%
CNC
Centene Corporation

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$27.13B
5Y Perf.-11.0%
CVS
CVS Health Corporation

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$111.40B
5Y Perf.+14.3%

AGL vs HUM vs UNH vs CNC vs CVS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
AGL logoAGL
HUM logoHUM
UNH logoUNH
CNC logoCNC
CVS logoCVS
IndustryMedical - Care FacilitiesMedical - Healthcare PlansMedical - Healthcare PlansMedical - Healthcare PlansMedical - Healthcare Plans
Market Cap$1.01B$29.67B$335.60B$27.13B$111.40B
Revenue (TTM)$5.82B$137.20B$449.71B$198.10B$407.90B
Net Income (TTM)$-373M$1.13B$12.04B$-6.44B$2.93B
Gross Margin-3.9%14.0%18.8%14.9%13.9%
Operating Margin-6.8%1.0%4.2%-3.7%1.5%
Forward P/E27.7x20.2x16.3x12.2x
Total Debt$37M$12.94B$78.39B$18.78B$93.59B
Cash & Equiv.$174M$4.20B$24.36B$17.89B$8.51B

AGL vs HUM vs UNH vs CNC vs CVSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

AGL
HUM
UNH
CNC
CVS
StockApr 21May 26Return
Agilon Health, Inc. (AGL)1007.7-92.3%
Humana Inc. (HUM)10055.5-44.5%
UnitedHealth Group … (UNH)10092.7-7.3%
Centene Corporation (CNC)10089.0-11.0%
CVS Health Corporat… (CVS)100114.3+14.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: AGL vs HUM vs UNH vs CNC vs CVS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: UNH leads in 3 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and dividend income and shareholder returns. Centene Corporation is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. CVS also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
AGL
Agilon Health, Inc.
The Healthcare Pick

AGL lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
HUM
Humana Inc.
The Insurance Pick

HUM is the clearest fit if your priority is growth exposure.

  • Rev growth 10.1%, EPS growth -1.4%, 3Y rev CAGR 11.7%
Best for: growth exposure
UNH
UnitedHealth Group Incorporated
The Insurance Pick

UNH carries the broadest edge in this set and is the clearest fit for long-term compounding.

  • 220.6% 10Y total return vs CNC's 81.2%
  • 2.7% margin vs AGL's -6.4%
  • 2.4% yield, 25-year raise streak, vs CVS's 3.1%, (2 stocks pay no dividend)
  • 3.9% ROA vs AGL's -24.5%, ROIC 9.2% vs -203.2%
Best for: long-term compounding
CNC
Centene Corporation
The Insurance Pick

CNC is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.

  • Lower volatility, beta 0.39, Low D/E 93.6%, current ratio 1.68x
  • 19.4% revenue growth vs AGL's -2.1%
  • Lower P/E (16.3x vs 20.2x)
Best for: sleep-well-at-night
CVS
CVS Health Corporation
The Insurance Pick

CVS ranks third and is worth considering specifically for income & stability and defensive.

  • Dividend streak 0 yrs, beta 0.05, yield 3.1%
  • Beta 0.05, yield 3.1%, current ratio 0.84x
  • Beta 0.05 vs AGL's 2.98
  • +34.7% vs AGL's -28.4%
Best for: income & stability and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthCNC logoCNC19.4% revenue growth vs AGL's -2.1%
ValueCNC logoCNCLower P/E (16.3x vs 20.2x)
Quality / MarginsUNH logoUNH2.7% margin vs AGL's -6.4%
Stability / SafetyCVS logoCVSBeta 0.05 vs AGL's 2.98
DividendsUNH logoUNH2.4% yield, 25-year raise streak, vs CVS's 3.1%, (2 stocks pay no dividend)
Momentum (1Y)CVS logoCVS+34.7% vs AGL's -28.4%
Efficiency (ROA)UNH logoUNH3.9% ROA vs AGL's -24.5%, ROIC 9.2% vs -203.2%

AGL vs HUM vs UNH vs CNC vs CVS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

AGLAgilon Health, Inc.
FY 2025
Medical Services
99.8%$5.9B
Other Operating
0.2%$11M
HUMHumana Inc.
FY 2025
Insurance Segment
84.7%$124.6B
CenterWell Segment
15.3%$22.5B
UNHUnitedHealth Group Incorporated
FY 2025
Unitedhealthcare
94.4%$332.4B
Optumhealth
5.6%$19.8B
CNCCentene Corporation
FY 2025
Medicaid Segment
75.8%$147.6B
Commercial Segment
21.6%$42.0B
Other Operating Segment
2.6%$5.1B
CVSCVS Health Corporation
FY 2025
Pharmacy Revenue
58.9%$229.0B
Premiums
34.6%$134.8B
Front Store Revenue
5.5%$21.5B
Product and Service, Other
1.0%$3.9B

AGL vs HUM vs UNH vs CNC vs CVS — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUNHLAGGINGHUM

Income & Cash Flow (Last 12 Months)

UNH leads this category, winning 4 of 6 comparable metrics.

UNH is the larger business by revenue, generating $449.7B annually — 77.3x AGL's $5.8B. UNH is the more profitable business, keeping 2.7% of every revenue dollar as net income compared to AGL's -6.4%. On growth, HUM holds the edge at +23.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricAGL logoAGLAgilon Health, In…HUM logoHUMHumana Inc.UNH logoUNHUnitedHealth Grou…CNC logoCNCCentene Corporati…CVS logoCVSCVS Health Corpor…
RevenueTrailing 12 months$5.8B$137.2B$449.7B$198.1B$407.9B
EBITDAEarnings before interest/tax-$366M$2.2B$23.2B-$5.9B$10.5B
Net IncomeAfter-tax profit-$373M$1.1B$12.0B-$6.4B$2.9B
Free Cash FlowCash after capex-$77M$1.3B$19.7B$6.3B$7.4B
Gross MarginGross profit ÷ Revenue-3.9%+14.0%+18.8%+14.9%+13.9%
Operating MarginEBIT ÷ Revenue-6.8%+1.0%+4.2%-3.7%+1.5%
Net MarginNet income ÷ Revenue-6.4%+0.8%+2.7%-3.3%+0.7%
FCF MarginFCF ÷ Revenue-1.3%+0.9%+4.4%+3.2%+1.8%
Rev. Growth (YoY)Latest quarter vs prior year-7.3%+23.5%+2.0%+7.1%+6.2%
EPS Growth (YoY)Latest quarter vs prior year+140.0%-4.6%+0.7%+18.3%+63.1%
UNH leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

CNC leads this category, winning 4 of 6 comparable metrics.

At 25.1x trailing earnings, HUM trades at a 60% valuation discount to CVS's 62.8x P/E. On an enterprise value basis, CVS's 13.1x EV/EBITDA is more attractive than HUM's 16.9x.

MetricAGL logoAGLAgilon Health, In…HUM logoHUMHumana Inc.UNH logoUNHUnitedHealth Grou…CNC logoCNCCentene Corporati…CVS logoCVSCVS Health Corpor…
Market CapShares × price$1.0B$29.7B$335.6B$27.1B$111.4B
Enterprise ValueMkt cap + debt − cash$873M$38.4B$389.6B$28.0B$196.5B
Trailing P/EPrice ÷ TTM EPS-2.48x25.12x27.95x-4.03x62.81x
Forward P/EPrice ÷ next-FY EPS est.27.68x20.19x16.29x12.19x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple16.87x16.70x13.11x
Price / SalesMarket cap ÷ Revenue0.17x0.23x0.75x0.14x0.28x
Price / BookPrice ÷ Book value/share7.92x1.68x3.31x1.35x1.47x
Price / FCFMarket cap ÷ FCF79.13x20.88x6.28x14.27x
CNC leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

UNH leads this category, winning 6 of 9 comparable metrics.

UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-146 for AGL. AGL carries lower financial leverage with a 0.29x debt-to-equity ratio, signaling a more conservative balance sheet compared to CVS's 1.24x. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs AGL's 2/9, reflecting solid financial health.

MetricAGL logoAGLAgilon Health, In…HUM logoHUMHumana Inc.UNH logoUNHUnitedHealth Grou…CNC logoCNCCentene Corporati…CVS logoCVSCVS Health Corpor…
ROE (TTM)Return on equity-146.0%+6.2%+11.5%-28.6%+3.9%
ROA (TTM)Return on assets-24.5%+2.2%+3.9%-7.9%+1.1%
ROICReturn on invested capital-2.0%+4.1%+9.2%-21.6%+5.0%
ROCEReturn on capital employed-108.4%+4.0%+9.7%-14.6%+6.1%
Piotroski ScoreFundamental quality 0–925665
Debt / EquityFinancial leverage0.29x0.73x0.77x0.94x1.24x
Net DebtTotal debt minus cash-$137M$8.7B$54.0B$889M$85.1B
Cash & Equiv.Liquid assets$174M$4.2B$24.4B$17.9B$8.5B
Total DebtShort + long-term debt$37M$12.9B$78.4B$18.8B$93.6B
Interest CoverageEBIT ÷ Interest expense-119.84x3.08x4.71x-9.03x2.11x
UNH leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CVS leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in CVS five years ago would be worth $11,700 today (with dividends reinvested), compared to $724 for AGL. Over the past 12 months, CVS leads with a +34.7% total return vs AGL's -28.4%. The 3-year compound annual growth rate (CAGR) favors CVS at 11.0% vs AGL's -54.6% — a key indicator of consistent wealth creation.

MetricAGL logoAGLAgilon Health, In…HUM logoHUMHumana Inc.UNH logoUNHUnitedHealth Grou…CNC logoCNCCentene Corporati…CVS logoCVSCVS Health Corpor…
YTD ReturnYear-to-date+260.1%-6.2%+10.6%+31.5%+10.6%
1-Year ReturnPast 12 months-28.4%-1.0%-3.2%-12.7%+34.7%
3-Year ReturnCumulative with dividends-90.6%-51.9%-19.9%-19.5%+36.6%
5-Year ReturnCumulative with dividends-92.8%-43.3%-2.6%-22.0%+17.0%
10-Year ReturnCumulative with dividends-92.2%+59.8%+220.6%+81.2%+3.5%
CAGR (3Y)Annualised 3-year return-54.6%-21.7%-7.1%-7.0%+11.0%
CVS leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

CVS leads this category, winning 2 of 2 comparable metrics.

CVS is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than AGL's 2.98 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVS currently trades 98.5% from its 52-week high vs AGL's 50.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricAGL logoAGLAgilon Health, In…HUM logoHUMHumana Inc.UNH logoUNHUnitedHealth Grou…CNC logoCNCCentene Corporati…CVS logoCVSCVS Health Corpor…
Beta (5Y)Sensitivity to S&P 5002.98x0.56x0.59x0.39x0.05x
52-Week HighHighest price in past year$119.50$315.35$395.52$64.15$88.63
52-Week LowLowest price in past year$0.97$163.11$234.60$25.08$58.35
% of 52W HighCurrent price vs 52-week peak+50.8%+78.4%+93.5%+85.7%+98.5%
RSI (14)Momentum oscillator 0–10060.476.675.983.569.3
Avg Volume (50D)Average daily shares traded373K1.6M7.9M5.8M7.4M
CVS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.

Analyst consensus: AGL as "Hold", HUM as "Hold", UNH as "Buy", CNC as "Buy", CVS as "Buy". Consensus price targets imply 9.0% upside for CVS (target: $95) vs -59.6% for AGL (target: $25). For income investors, CVS offers the higher dividend yield at 3.06% vs HUM's 1.44%.

MetricAGL logoAGLAgilon Health, In…HUM logoHUMHumana Inc.UNH logoUNHUnitedHealth Grou…CNC logoCNCCentene Corporati…CVS logoCVSCVS Health Corpor…
Analyst RatingConsensus buy/hold/sellHoldHoldBuyBuyBuy
Price TargetConsensus 12-month target$24.50$246.00$385.43$51.00$95.20
# AnalystsCovering analysts2544524341
Dividend YieldAnnual dividend ÷ price+1.4%+2.4%+3.1%
Dividend StreakConsecutive years of raises02510
Dividend / ShareAnnual DPS$3.56$8.70$2.67
Buyback YieldShare repurchases ÷ mkt cap+0.3%+0.5%+1.7%+1.8%0.0%
Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.
Key Takeaway

UNH leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CVS leads in 2 (Total Returns, Risk & Volatility). 1 tied.

Best OverallUnitedHealth Group Incorpor… (UNH)Leads 2 of 6 categories
Loading custom metrics...

AGL vs HUM vs UNH vs CNC vs CVS: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is AGL or HUM or UNH or CNC or CVS a better buy right now?

For growth investors, Centene Corporation (CNC) is the stronger pick with 19.

4% revenue growth year-over-year, versus -2. 1% for Agilon Health, Inc. (AGL). Humana Inc. (HUM) offers the better valuation at 25. 1x trailing P/E (27. 7x forward), making it the more compelling value choice. Analysts rate UnitedHealth Group Incorporated (UNH) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — AGL or HUM or UNH or CNC or CVS?

On trailing P/E, Humana Inc.

(HUM) is the cheapest at 25. 1x versus CVS Health Corporation at 62. 8x. On forward P/E, CVS Health Corporation is actually cheaper at 12. 2x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — AGL or HUM or UNH or CNC or CVS?

Over the past 5 years, CVS Health Corporation (CVS) delivered a total return of +17.

0%, compared to -92. 8% for Agilon Health, Inc. (AGL). Over 10 years, the gap is even starker: UNH returned +220. 6% versus AGL's -92. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — AGL or HUM or UNH or CNC or CVS?

By beta (market sensitivity over 5 years), CVS Health Corporation (CVS) is the lower-risk stock at 0.

05β versus Agilon Health, Inc. 's 2. 98β — meaning AGL is approximately 5790% more volatile than CVS relative to the S&P 500. On balance sheet safety, Agilon Health, Inc. (AGL) carries a lower debt/equity ratio of 29% versus 124% for CVS Health Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — AGL or HUM or UNH or CNC or CVS?

By revenue growth (latest reported year), Centene Corporation (CNC) is pulling ahead at 19.

4% versus -2. 1% for Agilon Health, Inc. (AGL). On earnings-per-share growth, the picture is similar: Humana Inc. grew EPS -1. 4% year-over-year, compared to -315. 8% for Centene Corporation. Over a 3-year CAGR, AGL leads at 35. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — AGL or HUM or UNH or CNC or CVS?

UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.

7% net margin versus -6. 8% for Agilon Health, Inc. — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -7. 1% for AGL. At the gross margin level — before operating expenses — UNH leads at 18. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is AGL or HUM or UNH or CNC or CVS more undervalued right now?

On forward earnings alone, CVS Health Corporation (CVS) trades at 12.

2x forward P/E versus 27. 7x for Humana Inc. — 15. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CVS: 9. 0% to $95. 20.

08

Which pays a better dividend — AGL or HUM or UNH or CNC or CVS?

In this comparison, CVS (3.

1% yield), UNH (2. 4% yield), HUM (1. 4% yield) pay a dividend. AGL, CNC do not pay a meaningful dividend and should not be held primarily for income.

09

Is AGL or HUM or UNH or CNC or CVS better for a retirement portfolio?

For long-horizon retirement investors, CVS Health Corporation (CVS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

05), 3. 1% yield). Agilon Health, Inc. (AGL) carries a higher beta of 2. 98 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CVS: +3. 5%, AGL: -92. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between AGL and HUM and UNH and CNC and CVS?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: AGL is a small-cap quality compounder stock; HUM is a mid-cap quality compounder stock; UNH is a large-cap quality compounder stock; CNC is a mid-cap high-growth stock; CVS is a mid-cap income-oriented stock. HUM, UNH, CVS pay a dividend while AGL, CNC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

AGL

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

HUM

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

UNH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Dividend Yield > 0.9%
Run This Screen
Stocks Like

CNC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
Run This Screen
Stocks Like

CVS

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 1.2%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform AGL and HUM and UNH and CNC and CVS on the metrics below

Revenue Growth>
%
(AGL: -7.3% · HUM: 23.5%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.